MedTrace Logo

A Comparative Study to Measure the Effect of Nebulized Dexmedetomidine

NCT05158348 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-12-15

No results posted yet for this study

Summary

A comparative study to measure the effect of nebulized dexmedetomidine - lidocaine for controlling postoperative pain after tonsillectomy in adults.

Conditions

  • Dexmedetomidine
  • Lidocaine
  • Tonsillectomy

Interventions

DRUG

Dexmedetomidine Hydrochloride

Group A will receive post-operative nebulised dexametomidine and lidocaine.

DRUG

Nebulized lidocaine

Group B will receive post-operative will receive nebulised lidocaine

DRUG

Local infiltration of lidocaine

group C will receive intra-operative local infiltration of lidocaine

Sponsors & Collaborators

  • Kasr El Aini Hospital

    lead OTHER

Principal Investigators

  • Dina Mohamed · Egypt Cairo university hospitals

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-05
Primary Completion
2022-04-10
Completion
2022-04-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05158348 on ClinicalTrials.gov